Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 22 Nov 2024
- Closes
- 7 Jan 2028, 23:59 UTC
- Reference
- PAR-25-281
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)”. Submissions close on 7 January 2028, 418 days from today. Quote reference PAR-25-281 in any correspondence with the buyer. FreeTender has recorded 459 notices from this buyer since 2023, 368 of them currently open. There are 389 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The purpose of this Notice of Funding Opportunity (NOFO) is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause transition (MT) in an effort to identity targets for future development of novel treatment interventions. This funding opportunity aims to advance novel and innovative translational research to better comprehend the underlying neurobiological and behavioral mechanisms of mood and psychosis disorders and related symptoms during MT. This funding opportunity also encourages interdisciplinary researchers to collaborate on studies of mood and psychosis during the MT. Aspects of mood and psychosis disorders that are of interest include: classic depressive symptoms in combination with menopause symptoms (e.g., hot flashes, night sweats, sleep disturbance) and psychological challenges, the role of reproductive steroids in the regulation of mood and behavior during the MT, diagnosis of mood and psychosis symptoms at menopausal stage, investigation of co-occurring psychiatric and menopause symptoms, appreciation of psychosocial factors common in midlife, and differential diagnoses. Review criteria will focus on the comprehensiveness of the neurobiology and mechanisms of action underlying mood and psychosis symptoms and hypothesis-driven work. Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
CFDA number(s): 93.242
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 459 notices from National Institutes of Health, going back to May 2023 — 368 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 389 open Healthcare & Pharma tenders in United States. This one closes in 418 days.
More from this buyer
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Research Centers (U01 Clinical Trial Not Allowed)· closes 5 Mar
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
- The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) Scientific Data Research Center (U24 Clinical Trial Not Allowed)· closes 5 Mar
- Research on System Support and Tools for Provider Training and Quality Monitoring for Suicide Preventive Care (RP1- Clinical Trial Optional)· closes 17 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Comprehensive Medical Services -FCI Pekin — General Health Care Services· closes 11 Feb
- Suction Apparatus, Surg — 40 each, NSN 6515016775151· closes 19 Nov
- Litter, Folding, Pole — 67 each, NSN 6530016631222· closes 18 Nov
- Blanket, Survival — 3000 each, NSN 6532015246932· closes 19 Nov
Explore United States
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Поставка аппликаторов грязевыхГОСУДАРСТВЕННОЕ АВТОНОМНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ОРДЕНА ТРУДОВОГО КРАСНОГО ЗНАМЕНИ "ГОРОДСКАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 1 Г. ЧЕЛЯБИНСК" · Russia
- Поставка лекарственных средств (растворов плазмозамещающих и перфузионных)ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ ПЕРМСКОГО КРАЯ "ПОЛАЗНЕНСКАЯ РАЙОННАЯ БОЛЬНИЦА" · Russia
- Поставка лекарственных препаратов МНН Десмопрессин, для льготной категории граждан на 2027 год (субвенция).СЛУЖБА РЕГУЛИРОВАНИЯ КОНТРАКТНОЙ СИСТЕМЫ В СФЕРЕ ЗАКУПОК РЕСПУБЛИКИ КАЛМЫКИЯ · Russia
- ПОСТАВКА ПРЕПАРАТА БЕКЛОМЕТАЗОН+ГЛИКОПИРРОНИЯ БРОМИД+ФОРМОТЕРОЛ для обеспечения граждан Российской Федерации, находящихся на территории Республики Бурятия, имеющих право на получение государственной социальной помощи в соответствии с Федеральным законом от 17 июля 1999 г. № 178-ФЗ «О государственной социальной помощи»РЕСПУБЛИКАНСКОЕ АГЕНТСТВО ПО ГОСУДАРСТВЕННЫМ ЗАКУПКАМ · Russia
- Лекарственный препарат для медицинского применения Кальция фолинатГОСУДАРСТВЕННОЕ УЧРЕЖДЕНИЕ ЗДРАВООХРАНЕНИЯ "ЛИПЕЦКИЙ ОБЛАСТНОЙ ОНКОЛОГИЧЕСКИЙ ДИСПАНСЕР" · Russia
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →